Zobrazeno 1 - 1
of 1
pro vyhledávání: '"J. M. Mareco"'
Autor:
A. B. Gómez Vara, T. Barbich, C. A. Isnardi, E. E. Schneeberger, G. Citera, V. V. Castro Coello, R. Baez, M. Haye, A. A. Reyes, J. A. Albiero, R. Tanten, E. Velozo, P. Alba, M. J. Gamba, C. G. Alonso, H. Maldonado Ficco, J. Gallino Yanzi, V. Savio, C. Asnal, C. Matellan, L. Takashima, L. Carlevaris, M. S. Gálvez Elkin, J. Scafati, M. García, N. German, M. L. Werner, C. Aeschlimann, S. E. Aguero, M. E. Calvo, L. Gonzalez Lucero, G. F. Rodriguez Gil, M. Mauri, S. Petruzzelli, D. Castrillon Bustamante, L. Ibañez Zurlo, D. Alonso, J. L. Tomas, D. L. Vasquez, S. Soares de Souza, N. Herscovich, L. Raiti, J. M. Mareco, D. Guaglianone, C. Ledesma, M. P. Diaz, M. E. Bedoya, B. Kisluk, G. Gómez, K. Roberts, R. Quintana, G. Pons-Estel
Publikováno v:
Annals of the Rheumatic Diseases. 81:953.1-953
BackgroundHigh disease activity, treatment with glucocorticoids (GC) and rituximab (RTX), have been related to worse outcomes of COVID-19.ObjectivesTo assess the clinical characteristics and severity of the SARS-CoV-2 infection in patients with rheum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be049046514246c9739f081a9a610486
https://doi.org/10.1136/annrheumdis-2022-eular.3000
https://doi.org/10.1136/annrheumdis-2022-eular.3000
